Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review. (Q36965617)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

0 references

familial hypercholesterolemia

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

L Iughetti

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

F Balli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

S Calandra

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

700-719

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Receptor-mediated endocytosis: insights from the lipoprotein receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Molecular genetics of the LDL receptor gene in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Beta-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

The apolipoprotein epsilon4 allele confers additional risk in children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Tolerance to organic nitrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Cardiovascular Health in Childhood: A Statement for Health Professionals From the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Risk and benefit of low fat intake in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Prospective randomised trial in 1062 infants of diet low in saturated fat and cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Prospective, randomized, infancy-onset trial of the effects of a low-saturated-fat, low-cholesterol diet on serum lipids and lipoproteins before school age: The Special Turku Coronary Risk Factor Intervention Project (STRIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Effect of 7-year infancy-onset dietary intervention on serum lipoproteins and lipoprotein subclasses in healthy children in the prospective, randomized Special Turku Coronary Risk Factor Intervention Project for Children (STRIP) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Testing for endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Endothelial function in healthy 11-year-old children after dietary intervention with onset in infancy: the Special Turku Coronary Risk Factor Intervention Project for children (STRIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Does a reduced fat diet cause retardation in child growth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Phytosterols and cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia: a prospective clinical follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Low dose colestipol in adolescents with familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Colestipol tablets in adolescents with familial hypercholesterolaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Treatment of hypercholesterolemia in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Reduced susceptibility of low density lipoprotein to lipid peroxidation after cholestyramine treatment in heterozygous familial hypercholesterolemic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Treatment of children with familial hypercholesterolemia with colestilan, a newly developed bile acid-binding resin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Early statin therapy restores endothelial function in children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Treatment of hypercholesterolaemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

The discovery and development of HMG-CoA reductase inhibitors. 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Developmental pharmacology--drug disposition, action, and therapy in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Improving lipid management--to titrate, combine or switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Statin safety: lessons from new drug applications for marketed statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

FDA adverse event reports on statin-associated rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

HMG-CoA reductase inhibitors and P-glycoprotein modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Atorvastatin treatment for hyperlipidemia in pediatric renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Effects of crystalline nicotinic acid-induced hepatic dysfunction on serum low-density lipoprotein cholesterol and lecithin cholesteryl acyl transferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Double blind trial of bezafibrate in familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Biological variations in hyperlipidemic children and adolescents treated with fenofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Circulating Antibodies Recognizing Oxidatively Modified Low-Density Lipoprotein in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347453

Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype

21 January 2018

1 reference

12 December 2020

A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)

1 reference

12 December 2020

Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia

1 reference

12 December 2020

Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol

1 reference

12 December 2020

Efficacy and safety of lowering dietary intake of total fat, saturated fat, and cholesterol in children with elevated LDL cholesterol: the Dietary Intervention Study in Children

1 reference

12 December 2020

Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood

1 reference

12 December 2020

Rational approach to pharmacologic reduction of cholesterol levels in children

1 reference

12 December 2020

Treatment of familial hypercholesterolemia with drugs in children

1 reference

12 December 2020

Dietary treatment for familial hypercholesterolaemia.

1 reference

12 December 2020

The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation

1 reference

12 December 2020

Diagnosis and treatment of primary hyperlipidemia in childhood. A Joint Statement for Physicians by the Committee on Atherosclerosis and Hypertension in Childhood of the Council of Cardiovascular Disease in the Young and the Nutrition Committee, Ame

1 reference

12 December 2020

Quality of life, anxiety and concerns among statin-treated children with familial hypercholesterolaemia and their parents

1 reference

12 December 2020

Growth during treatment of familial hypercholesterolemia

1 reference

12 December 2020

Simvastatin use in children

1 reference

12 December 2020

Influence of dietary fat on the nutrient intake and growth of children from 1 to 5 y of age: the Special Turku Coronary Risk Factor Intervention Project

1 reference

12 December 2020

Dietary therapy for children with hypercholesterolemia.

1 reference

12 December 2020

Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin

1 reference

12 December 2020

Special Turku Coronary Risk Factor Intervention Project for Babies (STRIP)

1 reference

12 December 2020

Growth failure. A complication of dietary treatment of hypercholesterolemia

1 reference

12 December 2020

The prevalence of side effects with regular and sustained-release nicotinic acid

1 reference

12 December 2020

Considerations about dietary fat restrictions for children

1 reference

12 December 2020

Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood

1 reference

12 December 2020

Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months

1 reference

12 December 2020

AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association

1 reference

12 December 2020

Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia.

1 reference

12 December 2020

American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents

1 reference

12 December 2020

Use of cholestyramine in the treatment of children with familial combined hyperlipidemia

1 reference

12 December 2020

Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine

1 reference

12 December 2020

Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia

1 reference

12 December 2020

Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation

1 reference

12 December 2020

Causes of death after renal transplantation

1 reference

12 December 2020

Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia

1 reference

12 December 2020

Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial

1 reference

12 December 2020

Mechanism of action of bile acid sequestrants and other lipid-lowering drugs

1 reference

12 December 2020

Influence of dietary intervention on growth in children with hypercholesterolaemia

1 reference

12 December 2020

Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group

1 reference

12 December 2020

"Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia

1 reference

12 December 2020

Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels

1 reference

12 December 2020

Neurological development of 5-year-old children receiving a low-saturated fat, low-cholesterol diet since infancy: A randomized controlled trial

1 reference

12 December 2020

Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters

1 reference

12 December 2020

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events?

1 reference

12 December 2020

Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia

1 reference

12 December 2020

Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation

1 reference

12 December 2020

Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). The Writing Group for the DISC Collaborative Research Group

1 reference

12 December 2020

The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia

1 reference

12 December 2020

American Academy of Pediatrics Committee on Nutrition: Statement on cholesterol

1 reference

12 December 2020

Influence of beta(0)-thalassemia on the phenotypic expression of heterozygous familial hypercholesterolemia : a study of patients with familial hypercholesterolemia from Sardinia

1 reference

12 December 2020

Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial

1 reference

12 December 2020

Niacin treatment of hypercholesterolemia in children

1 reference

12 December 2020

Safety and efficacy of treatment of children and adolescents with elevated low density lipoprotein levels with a step two diet or with lovastatin

1 reference

12 December 2020

Dietary intervention study in children (DISC) with elevated low-density-lipoprotein cholesterol. Design and baseline characteristics. DISC Collaborative Research Group

1 reference

12 December 2020

Lipoproteins, nutrition, and heart disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03347453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923804%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference